44 pct of Greeks would snub coronavirus vaccine

44 pct of Greeks would snub coronavirus vaccine

CSL Limited (ASX:CSL) today announced it has signed a Heads of Agreement (HoA) with the Australian Government for the supply of 51 million doses of the University of Queensland's (UQ) COVID-19 vaccine candidate (V451), and a separate HoA with AstraZeneca to manufacture the Oxford University candidate (AZD1222), should clinical trials of both prove successful.

The Greek government has said that any Covid-19 vaccine would not be compulsory but it will be "strongly recommended".

"Under the agreement, the University of Oxford/AstraZeneca and the University of Queensland/CSL will provide more than 84.8 million vaccine doses for the Australian population, nearly entirely manufactured in Melbourne, with early access to 3.8 million doses of the University of Oxford vaccine in January and February 2021", the Monday statement from the prime minister's office says.

If everything goes according to plan, the Oxford vaccines will be available from the beginning of 2021 while the UQ vaccines would be available from mid-2021.

He said CSL had been working at pace to respond to the pandemic and had invested significant resources in the rapid development and large-scale manufacture of the UQ vaccine, dubbed S-clamp.

If the Oxford vaccine trials prove successful and safe, it would be made available from the beginning of next year, while a UQ vaccine would be available mid-2021.

On Friday, J&J announced that countries like the USA and Belgium, where the company is already conducting testing of its COVID-19 vaccine, would be the first to get access to its shot.

Honor Watch GS and Honor Watch ES launched at IFA 2020
It's a lot lighter and thinner than those units, though, weighing just 21 grams without the strap and 10.7mm thick. The watch offers 24/7 heart-rate tracking which, again, makes that battery life claim look even more impressive.

University of Queensland researchers involved in the development of a coronavirus vaccine.

More than 95% of doses would be manufactured in Australia.

Late stage phase 3 trials are underway for the Oxford vaccine.

Morrison has stressed Australia wants to help Pacific countries and other regional neighbours get early access.

The Australian Government has reached agreements with pharmaceutical companies to secure 85 million doses of two COVID-19 vaccines to be distributed for free to Australians as early as January 2021.

Prime Minister Scott Morrison said that Australians could be some of the first in the world to receive the vaccines. CSL expects to take over the Phase 2 and 3 stages in late 2020, if the drug passes Phase 1. The vaccine is said to be easier to obtain dependable trial results in places with high rates of active infection and transmission.

Related Articles